Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
BioBehavioral Studies of Cardiovascular Disease
Sponsor: National Center for Complementary and Integrative Health (NCCIH)
A NA clinical study on Cardiovascular Diseases and Inflammation, this trial is completed. The trial is conducted by National Center for Complementary and Integrative Health (NCCIH) and has accumulated 7 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2021 — Sep 2021 [monthly]
Completed NA
Phase: PHASE2_PHASE3 → NA
-
Jan 2021 — Jun 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Jun 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Center for Complementary and Integrative Health (NCCIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- Office of Dietary Supplements (ODS)
- University of Pittsburgh
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Pittsburgh, United States